4. UNAIDS. Towards Universal Access: assessment by the Joint
United Nations Programme on HIV/AIDS on scaling up HIV
prevention, treatment, care and support. UNAIDS, Geneva,
9. Harries AD, Zachariah R, Lawn SD, Rosen S. Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health. 2010;15(Suppl 1):70–5. [PMC free article] [PubMed] 10. Rosen S, Fox MP. Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review. PLoS Med. 2011; 8(7):e1001056. [PMC free article] [PubMed] 11. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010;15(Suppl 1):1–15. [PMC free article] [PubMed] 14. Alsop Z. Kenya's HIV-testing drive runs into difficulties. Lancet. 2010;375(9722):1242. [PubMed]
16. Human Rights Watch, ARASA. A Testing Challenge: the
Experience of Lesotho’s Universal HIV Counseling and Testing
Campaign. Human Rights Watch, New York. 2008.
17. Amon JJ. Human Rights Watch 2006 World Report. New York: Seven Stories Press; 2006. Preventing the further spread of HIV/AIDS: the essential
role of human rights.
18. Cohen J, Tate T. The less they know the better: Abstinence-only HIV/AIDS programs in Uganda. Reprod Health Matters. 2006;14:174–8. [PubMed] 19. Amon JJ. Dangerous medicines: unproven AIDS cures and counterfeit antiretroviral drugs. Globalization and Health. 2008;4(5) [PMC free article] [PubMed]
20. Human Rights Watch. Where darkness knows no limits":
Incarceration, ill-treatment and forced labour as drug rehabilitation
in China. Human Rights Watch, New York. 2010.
21. Human Rights Watch. "Courage in the face of death: the Thai drug
users' network. Human Rights Watch, New York. 2004.
22. Human Rights Watch. "Skin on the Cable": The illegal arrest,
arbitrary detention and torture of people who use drugs in
Cambodia. Human Rights Watch, New York. 2010.
23. Human Rights Watch, ARASA. "Unjust and unhealthy". HIV, TB
and abuse in Zambian prisons. Human Rights Watch, New York. 2010.
24. Cohen JE, Amon JJ. Health and human rights concerns of drug users in detention in Guangxi Province, China. PLoS Med. 2008;5(12):e234. [PMC free article] [PubMed]
25. Human Rights Watch. Hated to death: homophobia, violence and
Jamaica's HIV/AIDS epidemic. Human Rights Watch, New York. 2004.
26. Amon JJ, Todrys KW. Fear of foreigners: HIV related restrictions on entry, stay and residence. J Int AIDS Soc. 2008;11(8) [PMC free article] [PubMed]
27. Human Rights Watch. "Neighbors in need". Zimbabweans seeking
refuge in South Africa. Human Rights Watch, New York. 2008.
28. Human Rights Watch. A test of inequality: discrimination against
women living with HIV in the Dominican Republic. Human Rights
Watch; New York. 2004.
29. Human Rights Watch. "No bright future". Government failures,
human rights abuses and squandered progress in the fight against
AIDS in Zimbabwe. Human Rights Watch, New York. 2006.
30. Human Rights Watch. "Hidden in the mealie meal". Gender-based
abuses and women's HIV treatment in Zambia. Human Rights
Watch, New York. 2007.
31. Human Rights Watch. "Future forsaken". Abuses against children
affected by HIV/AIDS in India. Human Rights Watch, New York. 2004.
32. Human Rights Watch. "Life doesn't wait". Romania's failure to
protect and support children and youth living with HIV. Human
Rights Watch, New York. 2006.
33. Human Rights Watch. "A question of life or death". Treatment
access for children living with HIV in Kenya. Human Rights
Watch, New York. 2008.
34. Gruskin S, Ahmed S, Ferguson L. Provider-initiated HIV testing and counseling in health facilities - What does this mean for the health and human rights of pregnant women? Developing World Bioeth. 2008;8(1):23–32. [PubMed]
35. Kahn JG, Granich R, Bennett R, et al. ART for prevention of HIV
transmission in South Africa: estimated cost and cost-effectiveness. International AIDS Society Conference; 2010 July 18-23; Vienna,
Austria. Abstract MOAE0405.
36. Hecht R, Bollinger L, Stover J, et al. Critical choices in financing the response to the global HIV/AIDS pandemic. Health Aff (Millwood) 2009;28(6):1591–605. [PubMed] 37. Brinkhof MW, Dabis F, Myer L, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86(7):559–67. [PubMed] 38. Lawn SD, Kranzer K, Wood R. Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings. Clin Chest Med. 2009;30(4):685–99. [PMC free article] [PubMed] 39. World Health Organization (WHO) Guidance on Provider-
Initiated HIV Testing and Counseling in Health Facilities. WHO,
Geneva, Switzerland 2007. Available at: http://www.who.int/hiv/pub/vct/pitc/en/ [Accessed August 3, 2011]. 40. Lugada E, Millar D, Haskew J, et al. Rapid implementation of an integrated large-scale HIV counseling and testing, malaria and diarrhea prevention campaign in rural Kenya. PLoS ONE. 2010;5(8):e12435. [PMC free article] [PubMed]
41. Grabowsky M, Lugada E, Mermin J, et al. Integrated HIV testing,
malaria, and diarrhea prevention campaign in Kenya: rapid, high
and equitable coverage. 5th International AIDS Society Conference
on HIV Pathogenesis, Treatment and Prevention; 2009 July 19-22; Cape Town, South Africa. Abstract CDD184.
43. Sachs JD, McArthur JW. The Millennium Project: a plan for meeting the Millennium Development Goals. Lancet. 2005;365(9456):347–53. [PubMed] 44. Bartlett JA, Hornberger J, Shewade A, Bhor M, Rajagopalan R. Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings. J Int Assoc Physicians AIDS Care. 2009;8(4):253–68. [PubMed] 45. Mshana GH, Wamoyi J, Busza J, et al. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDs. 2006;20(9):649–57. [PubMed] 46. Adeneye AK, Adewole TA, Musa AZ, et al. Limitations to Access and Use of Antiretroviral Therapy (ART) Among HIV Positive Persons in Lagos, Nigeria. World Health & Population. 2006;8(2):46–56. [PubMed] 47. Campero L, Herrera C, Kendall T, Caballero M. Bridging the gap between antiretroviral access and adherence in Mexico. Qual Health Res. 2007;17(5):599–611. [PubMed] 48. Larsson EC, Okong P, Thorson A, Ekstrom AM. Antiretroviral treatment of HIV in Uganda: a comparison of three different delivery models in a single hospital. Trans R Soc Trop Med Hyg. 2007;101(9):885–92. [PubMed] 49. Msellati P, Juillet-Amari A, Prudhomme J, et al. Socio-economic and health characteristics of HIV-infected patients seeking care in relation to access to the Drug Access Initiative and to antiretroviral treatment in Cote d'Ivoire. AIDS. 2003;17(Suppl 3):S63–8. [PubMed] 50. Xu J, Sullivan SG, Dou Z, et al. Economic stress and HIV-associated health care utilization in a rural region of China: A qualitative study. AIDS Patient Care STDs. 2007;21(11):787–97. [PubMed] 51. Farmer PE, Leandre F, Mukherjee JS, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet. 2001;358:404–9. [PubMed] 53. Bartlett JA, Hornberger J, Shewade A, Bhor M, Rajagopalan R. Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings. J Int Assoc Physicians AIDS Care. 2009;8(4):253–68. [PubMed] 54. Ramchandani SR, Mehta SH, Saple DG, et al. Knowledge, attitudes, and practices of antiretroviral therapy among HIV-infected adults attending private and public clinics in India. AIDS Patient Care STDs. 2007;21(2):129–42. [PubMed] 55. Kitajima T, Kobayashi Y, Chaipah W, et al. Access to antiretroviral therapy among HIV/AIDS patients in Khon Kaen Province, Thailand. AIDS Care. 2005;17(3):359–66. [PubMed] 56. Wringe A, Roura M, Urassa M, Busza J, Athanas V, Zaba B. Doubts, denial and divine intervention: understanding delayed attendance and poor retention rates at a HIV treatment programme in rural Tanzania. AIDS Care. 2009;21(5):632–7. [PubMed] 57. Mitchell MM, Knowlton A. Stigma, disclosure, and depressive symptoms among informal caregivers of people living with HIV/AIDS. AIDS Patient Care STDs. 2009;23(8):611–7. [PubMed] 58. Kip E, Ehlers VJ, van der Wal DM. Patients' adherence to anti-retroviral therapy in Botswana. J Nurs Scholarsh. 2009;41(2):149–57. [PubMed] 59. Posse M, Baltussen R. Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care STDs. 2009;23(10):867–75. [PubMed]
60. International HIV/AIDS Alliance. Antiretroviral treatment in
Zambia. A study of the experiences of treatment uses and health
care workers. International HIV/AIDS Alliance. 2004.
61. Amon JJ, Kasambala T. Structural barriers and human rights related to HIV prevention and treatment in Zimbabwe. Global Public Health. 2009;4(6):528–45. [PubMed]
62. Uganda AIDS Commission, UNAIDS. Uganda: HIV modes of
transmission and prevention response analysis. Uganda National
AIDS Commission, Kampala, Uganda. 2009.
64. Backman G, Hunt P, Khosla R, et al. Health systems and the right to health: an assessment of 194 countries. Lancet. 2008;372(9655):2047–85. [PubMed]
65. UNAIDS. Addressing human rights issues in national responses to
HIV. A review of programmes to reduce stigma and discrimination
and increase access to justice. UNAIDS, Geneva, Switzerland. 2009.
66. UNAIDS (submitted by the International Center for Research on
Women to UNAIDS) HIV-related stigma and discrimination: a
summary of recent literature. UNAIDS, Geneva, Switzerland. 2009.
67. International Planned Parenthood Federation, Global Network of
People Living with HIV/AIDS, International Community of
Women Living with HIV/AIDS. HIV - Verdict on a Virus: Public
Health, Human Rights and Criminal Law.”2008. Available at: http://www.gnpplus.net/images/stories/2008_verdict_on_a_virus.pdf . [Accessed July 20, 2011]. 69. Sherer R. Physician use of the HIV antibody test. The need for
consent, counseling, confidentiality and caution. J Am Med Assoc. 1988;259:264–5. [PubMed] 71. Rennie S, Behets F. Desperately seeking targets: the ethics of routine HIV testing in low-income countries. Bull World Health Organ. 2006;84(1):52–7. [PubMed] 72. McQuoid-Mason D. Routine testing for HIV--ethical and legal implications. S Afr Med J. 2007;97(6):416. [PubMed] 73. Csete J, Elliott R. Scaling up HIV testing: human rights and hidden costs. HIV AIDS Policy Law Rev. 2006;11(1):1. [PubMed] 74. Csete J, Schleifer R, Cohen J. "Opt-out" testing for HIV in Africa: a caution. Lancet. 2004;363:493–4. [PubMed] 75. Kenyon K. Routine HIV testing:a view from Botswana. Health and human rights. 2005;8:21–3. [PubMed] 76. Leon N, Naidoo P, Mathews C, Lewin S, Lombard C. The impact of provider-initiated (opt-out) HIV testing and counseling of patients with sexually transmitted infection in Cape Town, South Africa: a controlled trial. Implementation Sci. 2010;8:8. [PMC free article] [PubMed] 78. Were W, Mermin J, Bunnell R, Ekwaru JP, Kaharuza F. Home-based model for HIV voluntary counselling and testing. Lancet. 2003;361(9368):1569. [PubMed] 79. Abadia-Barrero CE, Castro A. Experiences of stigma and access to HAART in children and adolescents living with HIV/AIDS in Brazil. Soc Sci Med. 2006;62:1219–28. [PubMed] 80. Castro A, Farmer PE. Understanding and addressing AIDS-related stigma: from anthropological theory to clinical practice in Haiti. Am J Public Health. 2005;95:53–9. [PubMed] 81. Herek GM, Capitanio JP, Widaman KF. HIV-related stigma and knowledge in the United States: prevalence and trends, 1991-1999. Am J Public Health. 2002;92:371–7. [PubMed] 82. Levy N, Miksad R, Fein O. From treatment to prevention: the interplay between HIV/AIDS prevention programming in Khayelitsha, South Africa. J Urban Health. 2005;82:498–509. [PMC free article] [PubMed] 83. Wolfe WR, Weiser SD, Leiter K, et al. The impact of universal access to antiretroviral therapy on HIV stigma in Botswana. Am J Public Health. 2008;98:1865–71. [PubMed] 84. Apondi R, Bunnell R, Awor A, et al. Home-based antiretroviral care is associated with positive social outcomes in a prospective cohort in Uganda. J Acquir Immune Defic Syndr. 2007;44:71–6. [PubMed] 85. Daftary A, Padayatchi N, Padilla M. HIV testing and disclosure: a qualitative analysis of TB patients in South Africa. AIDS Care. 2007;19(4):572–7. [PubMed] 87. Wu S, Li L, Wu Z, et al. A brief stigma reduction intervention for service providers in China. AIDS Patient Care STDs. 2008;22(6):513–20. [PMC free article] [PubMed] 88. Warner-Smith M, Rugg D, Frescura L, Moussavi S. Monitoring the 2001 Declaration of Commitment on HIV/AIDS. J Acquir Immune Defic Syndr. 2009;52(Suppl 2):S77–86. [PubMed]
89. Mann J. Statement at an informal briefing on AIDS to the 42nd session of the United Nations General Assembly. New York. 1987.
90. Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57:13–24. [PubMed] 91. Mann JM. Global AIDS: critical issues for prevention in the 1990s. Int J Health Serv. 1991;21(3):553–9. [PubMed]
92. UNAIDS. Reducing HIV stigma and discrimination: a critical part
of national AIDS programmes. A resource for national stakeholders
in the HIV reponse. UNAIDS, Geneva, Switzerland. 2007.
93. Weiser SD, Wolfe WR, Bangsberg D, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34:281–8. [PubMed] 94. Andersson N, Ho-Foster A, Mitchell SK, Scheepers E, Goldstein S. Risk factors for domestic physical violence: national cross-sectional household surveys in eight southern African countries. BMC Women's Health. 2007;7(11) [PMC free article] [PubMed] 95. Franke MF, Munoz M, Finnegan K, et al. Validation and
Abbreviation of an HIV Stigma Scale in an Adult Spanish-Speaking Population in Urban Peru. AIDS Behav. 2008. pp. 1–11. [PubMed] 96. Uys LR, Holzemer WL, Chirwa ML, et al. The development and
validation of the HIV/AIDS Stigma Instrument - Nurse (HASI-N).
AIDS Care - Psychological and Socio-Medical. Aspects of
AIDS/HIV. 2009;21(2):150–9. [PMC free article] [PubMed] 98. Maxwell C, Boyle M. Risky heterosexual practices amongst women over 30: gender, power and long term relationships. AIDS Care. 1995;7(3):277–93. [PubMed] 99. Gysels M, Pool R, Nnalusiba B. Women who sell sex in a Ugandan trading town: life histories, survival strategies and risk. Soc Sci Med. 2002;54(2):179–92. [PubMed] 100. Morojele NK, Brook JS, Kachleng'a MA. Perceptions of sexual risk behaviours and substance abuse among adolescents in South Africa: a qualitative investigation. AIDS Care. 2006;18(3):215–9. [PubMed] 101. Clark S, Bruce J, Dude A. Protecting young women from HIV/AIDS: the case against child and adolescent marriage. Int Fam Plan Perspect. 2006;32(2):79–88. [PubMed] 102. Dunkle KL, Jewkes RK, Brown HC, Gray GE, McIntryre JA, Harlow SD. Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. Lancet. 2004;363(9419):1415–21. [PubMed] 103. van der Straten A, King R, Grinstead O, Serufilira A, Allen S. Couple communication, sexual coercion, and HIV risk reduction in Kigali, Rwanda. AIDS. 1995;9(8):935–44. [PubMed]
104. van der Straten A, King R, Grinstead O, Vittinghoff E, Serufilira A, Allen S. Sexual Coercion, Physical Violence, and HIV Infection Among Women in Steady Relationships in Kigali, Rwanda. AIDS Behav. 1998;2(1):61–73.
105. Andersson N, Cockcroft A, Shea B. Gender-based violence and HIV: relevance for HIV prevention in hyperendemic countries of southern Africa. AIDS. 2008;22(Supplement 4):S73–S86. [PubMed] 106. World Health Organization (WHO) Department of Gender, Women
and Health; WHO Cluster of Family and Community Health.
Gender dimensions of HIV status disclosure to sexual partners:
Rates, barriers and outcomes. A review paper. WHO, Geneva,
Switzerland 2003. Available at: http://www.who.int/gender/documents/women_and_girls/9241590734/en/index.html . [Accessed
August 3, 2011]. 107. Cartoux M, Meda N, Van de Perre P, Newell ML, de Vincenzi I, Dabis F. Acceptability of voluntary HIV testing by pregnant
women in developing countries: an international survey. Ghent
Working Group on Mother-to Child Transmission of HIV. AIDS. 1998;12(18):2489–93. [PubMed] 108. Maman S, Mbwambo J, Hogan NM, Kilonzo GP, Sweat M. Women's barriers to HIV-1 testing and disclosure: challenges for HIV-1 voluntary counselling and testing. AIDS Care. 2001;3(5):595–603. [PubMed] 109. de Paoli MM, Manongi R, Klepp KI. Factors influencing acceptability of voluntary counselling and HIV-testing among pregnant women in Northern Tanzania. AIDS Care. 2004;16(4):411–25. [PubMed]
110. Msellati P. Vers une proposition du test VIH aux femmes enceintes. Journal SIDA. 1996;86-87:90–1.
112. Allen S, Tice J, Van de Perre P, et al. Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. Br Med J. 1992;304(6842):1605–9. [PMC free article] [PubMed]
113. Kairania R, Gray RH, Kiwanuka N, et al. Vers une proposition du test VIH auz femmes enceintes. Journal SIDA. 1996;86-87:90–1.
114. Dunkle KL, Stephenson R, Karita E, et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet. 2008;371(9631):2183–91. [PubMed] 115. Bunnell R, Ekwaru JP, Solberg P, et al. Changes in sexual behavior
and risk of HIV transmission after antiretroviral therapy and
prevention interventions in rural Uganda. AIDS. 2006;20(1):85–92. [PubMed] 116. Allen S, Tice J, Van de Perre P, et al. Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. Br Med J. 1992;304:1605–9. [PMC free article] [PubMed] 117. The Voluntary HIV-1 Counselling and Testing Efficacy Study
Group. Efficacy of voluntary HIV-1 counselling and testing in
individuals and couples in Kenya, Tanzania and Trinidad: a
randomised trial. Lancet. 2000;356(9224):103–12. [PubMed] 118. Amnesty International. 'I am at the lowest end of all': rural women
living with HIV face human rights abuses in South Africa.
Amnesty International, London, United Kingdom 2008. Available at: www.amnesty.org/en/library/info/AFR53/001/2008/en . [Accessed August 3, 2011].
119. Meth P. The shelter dilemma for women experiencing domestic violence. Agenda. 2001;48:113–9.
120. World Health Organization (WHO) Rapid advice: use of
antiretroviral drugs for treating pregnant women and preventing
HIV infection in infants. WHO, Geneva, Switzerland 2009. Available at: http://www.who.int/hiv/pub/mtct/advice/en/index.html . [Accessed August 3, 2011].
121. Human Rights Watch. Statement to the human rights council on the
protection of human rights in the context of HIV/AIDS. Human
Rights Watch, New York. 2009.
122. Todrys KW, Amon JJ. Within but without: human rights and access to HIV prevention and treatment for internal migrants. Global Health. 2009;19(5):17. [PMC free article] [PubMed] 123. United Nations. Resolution adopted by the General Assembly.
Declaration of commitment on HIV/AIDS. United Nations 2001. Available at: www.un.org/ga/aids/docs/aress262.pdf . [Accessed August 3, 2011].